Surmodics, Inc., a $107m maker of surface modification technologies for intravascular medical devices, has acquired Vetex Medical Ltd, an Ireland–based producer of venous clot removal products. Vetex developed ReVene, a thrombectomy catheter platform that is used to remove, in a single session, large, mixed-morphology blood clots commonly found in venous thromboembolism. Deal value – $40m upfront with milestones up to …
Tecan Group Acquires Paramit for $1b
Tecan Group Ltd, a $795m Switzerland-based global provider of laboratory instruments and solutions in life science research and clinical diagnostics, has acquired Paramit Corporation, a maker of electronics based medical devices and life science instruments. The deal accelerates Tecan’s entry into medical devices and enhances Paramit’s capabilities and market leadership in life sciences. Paramit provides fully integrated engineering, manufacturing, and …
DENTSPLY SIRONA Inc. Acquires Propel Orthodontics for $131M
DENTSPLY SIRONA (Nasdaq: XRAY), a $3.3b provider of dental technologies, equipment and consumables has acquired Propel Orthodontics, developer of the VPro, a vibratory orthodontic device that seats aligners in 5 minutes a day for at-home use. The VPro device is used with Propel’s Fastrack Mobile App that patients can use to track usage and share information with providers online. The …
Japan-based Olympus Corporation Acquires Israel-based Medi-Tate
Adds an in-office treatment for benign prostatic hyperplasia (BPH) treatment to Olympus’ leading urological devices portfolio. Medi-Tate‘s “iTind” has received FDA de Novo authorization and a European CE mark. Since November 2018, Olympus secured distribution rights to iTind via an initial investment. The incidence of BPH is one of the most common diseases in aging men and the most common …
GE Healthcare Buys Molecular Imaging Agent Producer Zionexa
General Electric (NYSE: GE), through its $18b healthcare business GE Healthcare, has acquired France-based Zionexa, the developer of a positron emission tomography (PET) imaging agent, Cerianna, used as an adjunct to biopsy for the detection of estrogen receptor (ER) positive lesions in recurrent or metastatic breast cancer care. Cerianna was FDA-approved in mid-2020 and commercialized in December 2020. ~168,000 people …
The Walden Group Advises ASICO, LLC in its Sale to Katena Products, Inc.
The Walden Group is pleased to announce that it represented ASICO, LLC in its sale to Katena Products, Inc. The principals of ASICO engaged Walden, in large part, due to its substantial track record and experience in regard to ophthalmic industry transactions. Walden had represented: Katena in its 2009 sale to Cortec Group and its subsequent purchase of IOP (amniotic …
Erbe Elektromedizin GmbH Buys Maxer Endoscopy
Germany-based Erbe Elektromedizin, a producer of electrosurgery, plasmasurgery and cryotherapy generators, has bought Germany-based Maxer Endoscopy, adding a range of endoscopic visualization systems for use in laparoscopy, hysteroscopy, urology, pediatric surgery, arthroscopy, spine endoscopy and ENT surgery. Maxer’s line of endoscopes, light sources, cameras and more add fluorescence imaging guidance, akin to a “GPS system” that will improve surgical accuracy …
SeaSpine Buys 7D Surgical for $110m
SeaSpine (Nasdaq: SPNE), a $154m developer of orthobiologics and spinal implant solutions is paying $110m to buy Canada-based 7D Surgical, the producer of a machine-vision, image-guided surgery platform with applications in spine and cranial surgeries. 7D’s system reduces radiation exposure by eliminating intra-operative CT (computed tomography) and fluoroscopy for purposes of registration, both commonly used with traditional navigational systems. In …
Agilent Technologies Purchases Resolution Bioscience in $550m Deal
Agilent Technologies (SYSE: A), a $5.3b analytical instrumentation development and manufacturing company, is buying Resolution Bioscience, maker of a non-invasive liquid biopsy platform, for $550m upfront plus additional milestones of up to $145m. Resolution Bioscience’s ctDx test can detect all four major types of genetic alterations known to drive cancers and has a turnaround time of a few days. …
Hologic Pays $159m for Belgium-based Molecular Diagnostic Assay Developer Diagenode
Hologic, a $3.8b developer of diagnostics, imaging systems, and surgical products for women’s health, is buying epigenetics analysis company Diagenode, adding a menu of 30 real-time PCR (polymerase chain reaction) tests that are CE-marked for the detection of bacteria, parasites and viruses involved in sexually transmitted diseases, respiratory diseases, meningitis and gastroenteritis. Diagenode previously collaborated with Hologic to develop assays …